gene expression
Investigators presented data from a meta-analysis that suggests the firm's POLAR gene expression test can identify patients unlikely to benefit from radiation.
The firm cited new study results confirming that an assay analyzing circulating tumor cells isolated by its Parsortix platform can discriminate malignant pelvic masses.
DxTerity Gets New York State Authorization for Systemic Lupus Erythematosus Test
The test is used to identify patients less likely to respond to standard treatment and more likely to develop a severe kidney disorder.
Canhelp Genomics Secures NMPA Approval for Pan-Cancer Tissue-Origin Assay, Analysis Software
The Canhelp-Origin Test measures the gene expression pattern of 90 specific markers of tissue samples and classifies 21 major tumor types.
Agendia Building Validation Data on ImPrint for Guiding Neoadjuvant Immunotherapy in Breast Cancer
Premium
The firm envisions marketing the 53-gene signature with its existing MammaPrint and BluePrint tests as a comprehensive platform for breast cancer treatment selection.